ABCA4 and eye disorder: In addition to clinical diagnosis by an inherited retinal disease expert, all included patients were molecularly-confirmed with two pathogenic variants in ABCA4. The study included scans from consecutive patients seen within an inherited eye disease clinic, and thus were less susceptible to selection bias from strict inclusion criteria as might be seen in a prospective clinical trial.